# Clinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain

Study · id `cardio:ct-nct05857904` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05857904](<https://clinicaltrials.gov/study/NCT05857904>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05857904

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 4648 participants.

## Technical summary

Registry record NCT05857904. Randomized; single masking; primary purpose other. Start 2023-05 (anticipated); primary completion 2025-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose other
- Phase: Not applicable
- Enrolled: 4648 participants (planned count; ClinicalTrials.gov record NCT05857904, source copy `cardio:ctgov-nct05857904-2023-05-15`, retrieved 2026-10-26)
- Planned start: 2023-05 (anticipated) (ClinicalTrials.gov record NCT05857904, source copy `cardio:ctgov-nct05857904-2023-05-15`, retrieved 2026-10-26)
- Primary completion: 2025-05 (anticipated) (ClinicalTrials.gov record NCT05857904, source copy `cardio:ctgov-nct05857904-2023-05-15`, retrieved 2026-10-26)
- Completion: 2028-05 (anticipated) (ClinicalTrials.gov record NCT05857904, source copy `cardio:ctgov-nct05857904-2023-05-15`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05857904, source copy `cardio:ctgov-nct05857904-2023-05-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05857904-2023-05-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain
- Acronym: CONFIDENT
- Condition: Angina, Stable
- Condition: Coronary Artery Disease
- Intervention (Device): CT-FFR
- Intervention (Device): QFR
- Lead sponsor: Shanghai Zhongshan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry lists this organization as the lead sponsor: Shanghai Zhongshan Hospital (`cardio:org-shanghai-zhongshan-hospital`)

## Provenance

Content hash: 3daa9a9702e573c0dbb7646302c9c13c6e4b3657f57fe1c5b7b99772db56f8bb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
